Company
Histosonics
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
4
510(k), De Novo and PMA
Device trials
10
As lead sponsor, any status
Adverse event reports
70
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$308M
9 Form D offerings, 2009 to 2024
Equity
$213M
Stock sold for cash
Debt and convertible notes
$95.6M
$10.6M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $102M raised of $102M sought, first sale Jul 31, 2024, 39 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Jul 31, 2024 | Equity | $102M | $102M | 39 | Rule 506(b) | Form D ↗Aug 15, 2024 |
| Dec 12, 2022 | Debt | $85.0M | $85.0M | 38 | Rule 506(b) | Form D ↗Dec 27, 2022 |
| Apr 15, 2020 | Equity | $40.8M | $40.8M | 24 | Rule 506(b) | Form D/A ↗Jun 12, 20201 amendment |
6 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- HistoSonics, Inc.
- Headquarters
- Plymouth, Minnesota
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1479012 ↗
Executives, directors and promoters
As listed on the latest Form D.
9 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Histosonics.
Latest FDA decisions
K252947 · Decided May 29, 2026 · 256 days after receipt
Device type: Radiological Image Processing Software For Ablation Therapy Planning And Evaluation (QTZ) · Radiology & Imaging
- Edison System510(k)
K241902 · Decided Oct 30, 2024 · 121 days after receipt
Device type: Focused Ultrasound System For Non-Thermal, Mechanical Tissue Ablation (QGM) · General & Plastic Surgery
- Edison System510(k)
K233466 · Decided Mar 13, 2024 · 141 days after receipt
Device type: Focused Ultrasound System For Non-Thermal, Mechanical Tissue Ablation (QGM) · General & Plastic Surgery
1 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT06486454 · 5,000 participants (planned) · Start Oct 14, 2024 · Primary completion Nov 2034
Device: HistoSonics Edison System · For: Liver Neoplasms; Primary Liver Cancer; Secondary Liver Cancer and 2 more
Sites: Mobile, Alabama; Fullerton, California; Los Angeles, California · 35 sites in all
- The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using HistotripsyCompleted
NCT05432232 · 20 participants · Start Mar 23, 2023 · Primary completion Dec 28, 2024
Device: HistoSonics Investigational System · For: Renal Cancer; Tumor, Solid; Kidney Cancer and 3 more
Sites: Leeds, United Kingdom
- The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using HistotripsyRecruiting
NCT06282809 · 50 participants (planned) · Start Dec 10, 2024 · Primary completion Mar 2028
Device: HistoSonics Edison™ System for the treatment of pancreatic adenocarcinoma using histotripsy · For: Pancreas Cancer; Adenocarcinoma of the Pancreas; Pancreatic Cancer and 1 more
Sites: Barcelona, Spain
7 more trials with a free account
Reports received
70
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
0.0% of reports
Injury reports
63
90% of reports
Death reports
7
10% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 3 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 1 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 4 | 0 | 0 |
| May 25 | 0 | 3 | 2 | 0 |
| Jun 25 | 0 | 3 | 0 | 0 |
| Jul 25 | 0 | 2 | 0 | 0 |
| Aug 25 | 0 | 3 | 1 | 0 |
| Sep 25 | 0 | 2 | 3 | 0 |
| Oct 25 | 0 | 7 | 0 | 0 |
| Nov 25 | 0 | 1 | 1 | 0 |
| Dec 25 | 0 | 8 | 2 | 0 |
| Jan 26 | 0 | 2 | 1 | 0 |
| Feb 26 | 0 | 1 | 0 | 0 |
| Mar 26 | 0 | 10 | 0 | 0 |
| Apr 26 | 0 | 6 | 0 | 0 |
| May 26 | 0 | 5 | 2 | 0 |
| Jun 26 | 0 | 5 | 0 | 0 |
| Jul 26 | 0 | 5 | 0 | 0 |
| Aug 26 | 0 | 7 | 0 | 0 |
| Sep 26 | 0 | 9 | 1 | 0 |
| Oct 26 | 0 | 4 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- EDISON65
1 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.